Interleukin-2/anti-interleukin-2 complex attenuates inflammation in a mouse COPD model by expanding CD4 < sup > + < /sup > CD25 < sup > + < /sup > Foxp3 < sup > + < /sup > regulatory T cells

CONCLUSIONS AND IMPLICATIONS: IL-2C is a potential therapeutic agent for alleviating excessive inflammation in the lungs of patients with COPD.PMID:38503017 | DOI:10.1016/j.intimp.2024.111849

Source: International Immunopharmacology - March 19, 2024 Category: Allergy & Immunology Authors: Ruirui Duan Ke Huang Tao Yu Chenli Chang Xu Chu Yuhang Huang Zhoude Zheng Linxi Ma Baicun Li Ting Yang Source Type: research